Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases (Q40064488)

17 September 2017

title

Eight-channel iTRAQ enables comparison of the activity of six leukemogenic tyrosine kinases (English)

1 reference

17 September 2017

1 reference

17 September 2017

Richard D Unwin

0 references

Crispin J Miller

0 references

Anthony D Whetton

0 references

Elaine Spooncer

1 reference

17 September 2017

Caroline A Evans

1 reference

17 September 2017

Stephen Griffiths

1 reference

17 September 2017

Louise Carney

1 reference

17 September 2017

Liqun Zhang

1 reference

17 September 2017

Ewa Jaworska

1 reference

17 September 2017

Chia-Fang Lee

1 reference

17 September 2017

David Blinco

1 reference

17 September 2017

Michal J Okoniewski

1 reference

17 September 2017

Danny A Bitton

1 reference

17 September 2017

publication date

21 October 2007

1 reference

Molecular & Cellular Proteomics

17 September 2017

published in

1 reference

17 September 2017

1 reference

17 September 2017

1 reference

17 September 2017

page(s)

853-863

1 reference

The impact of translocations and gene fusions on cancer causation

17 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

An alteration of the human c-abl protein in K562 leukemia cells unmasks associated tyrosine kinase activity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Fusion of PDGF receptor beta to a novel ets-like gene, tel, in chronic myelomonocytic leukemia with t(5;12) chromosomal translocation

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

A tyrosine kinase created by fusion of the PDGFRA and FIP1L1 genes as a therapeutic target of imatinib in idiopathic hypereosinophilic syndrome

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Fusion of a kinase gene, ALK, to a nucleolar protein gene, NPM, in non-Hodgkin's lymphoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

The development of imatinib as a therapeutic agent for chronic myeloid leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Quantitative proteomics reveals posttranslational control as a regulatory factor in primary hematopoietic stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Quantitative proteomic analysis using isobaric protein tags enables rapid comparison of changes in transcript and protein levels in transformed cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Multiplexed protein quantitation in Saccharomyces cerevisiae using amine-reactive isobaric tagging reagents

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Bioconductor: open software development for computational biology and bioinformatics

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Summaries of Affymetrix GeneChip probe level data

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

An annotation infrastructure for the analysis and interpretation of Affymetrix exon array data

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

The Paragon Algorithm, a next generation search engine that uses sequence temperature values and feature probabilities to identify peptides from tandem mass spectra

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT Method

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Lysophospholipids synergistically promote primitive hematopoietic cell chemotaxis via a mechanism involving Vav 1

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Oncogenic Abl and Src tyrosine kinases elicit the ubiquitin-dependent degradation of target proteins through a Ras-independent pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Comparisons of CapG and gelsolin-null macrophages: demonstration of a unique role for CapG in receptor-mediated ruffling, phagocytosis, and vesicle rocketing

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Comparative proteomics of primitive hematopoietic cell populations reveals differences in expression of proteins regulating motility

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

The tumor suppressor PP2A is functionally inactivated in blast crisis CML through the inhibitory activity of the BCR/ABL-regulated SET protein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

ReSETting PP2A tumour suppressor activity in blast crisis and imatinib-resistant chronic myelogenous leukaemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Chronic myeloid leukemia CD34+ cells have elevated levels of phosphatidylinositol 3,4,5 trisphosphate (PtdIns(3,4,5)P3) and lack a PtdIns(3,4,5)P3 response to cytokines and chemotactic factors; effects reversed by imatinib.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Differential effect of leukaemogenic tyrosine kinases on cell motility is governed by subcellular localisation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Molecular regulation of receptor tyrosine kinases in hematopoietic malignancies

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Genetic abnormalities as targets for molecular therapies in myelodysplastic syndromes

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Oncogenic mechanisms in myeloproliferative disorders

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Fusion tyrosine kinases: a result and cause of genomic instability

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

BCR/ABL induces multiple abnormalities of cytoskeletal function

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Translational regulation by the p210 BCR/ABL oncoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

The biology of CML blast crisis

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Ba/F3 cells and their use in kinase drug discovery

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Multiple reaction monitoring for robust quantitative proteomic analysis of cellular signaling networks

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

Dasatinib induces notable hematologic and cytogenetic responses in chronic-phase chronic myeloid leukemia after failure of imatinib therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1074%2FMCP.M700251-MCP200

10.1074/MCP.M700251-MCP200

21 January 2018

Identifiers

DOI

1 reference

release_7jkyp2smgvgmpjzr54vyvg7exy

17 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/7jkyp2smgvgmpjzr54vyvg7exy

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference